(Q38695603)

5 September 2017

title

Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma (English)

1 reference

5 September 2017

1 reference

6

1 reference

5 September 2017

Samuel Mueller

4

0 references

Jean Yang

object named as

Jean Yang

8

0 references

Graham J Mann

object named as

Graham J Mann

7

0 references

author name string

Kaushala Jayawardana

1

1 reference

5 September 2017

Sarah-Jane Schramm

2

1 reference

5 September 2017

Varsha Tembe

3

1 reference

5 September 2017

John F Thompson

5

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Journal of Investigative Dermatology

5 September 2017

published in

1 reference

5 September 2017

volume

136

1 reference

5 September 2017

issue

1

1 reference

5 September 2017

page(s)

245-254

1 reference

https://scigraph.springernature.com/pub.10.1038/jid.2015.355

5 September 2017

exact match

0 references

cites work

Genomic Classification of Cutaneous Melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Final version of 2009 AJCC melanoma staging and classification

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Significance analysis of prognostic signatures

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

MicroRNA expression profiles associated with mutational status and survival in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Tissue prognostic biomarkers in primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Review and cross-validation of gene expression signatures and melanoma prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Molecular biomarkers of prognosis in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Biospecimen banking: the pathway to personalized medicine for patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Melanoma MicroRNA signature predicts post-recurrence survival

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Narrowing the knowledge gaps for melanoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Diagnosis of multiple cancer types by shrunken centroids of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Melanoma molecular classes and prognosis in the postgenomic era.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Most random gene expression signatures are significantly associated with breast cancer outcome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2015.355

7 January 2021

Identifiers

DOI

10.1038/JID.2015.355

1 reference

Dimensions Publication ID

5 September 2017

1026065871

0 references

1 reference